Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer
{{output}}
Background & aims: The use of surrogate endpoints in trials including biliary tract cancers (BTC) is growing. While this may expedite drug approval and decrease costs, it may not always correlate with an overall survival (OS) adv... ...
